Drug Topics

FEBRUARY 10, 2023

The number of digital therapeutics available for migraine is likely to expand.

201

201

Pharmaceutical Technology

FEBRUARY 10, 2023

4D Molecular Therapeutics (4DMT), the California-based biotechnology company focused on developing gene therapies for rare and large market diseases, has had the FDA place a clinical hold onto its Fabry disease (FD) gene therapy program (4D-310). 4DMT had paused enrollment of patients to two of its trials for 4D-310 last month following a significant adverse event where three patients experienced kidney issues; however, these were treated and resolved in a four-week period. 4DMT has stated that

FDA 105

FDA Insurance Coverage Insurance 105

European Pharmaceutical Review

FEBRUARY 10, 2023

Changes to management for Big Pharma companies Astellas and Bayer AG have been announced for 2023. Astellas Astellas Pharma Inc. has approved changes of its Representative Director, President and CEO and its management structure. Effective April 1, 2023, Naoki Okamura and Kenji Yasukawa will hold the following positions: Naoki Okamura is currently Representative Director, Executive Vice President of Astellas.

102

102

Pharmaceutical Technology

FEBRUARY 10, 2023

On November 22, 2022, the FDA approved CSL Behring’s Hemgenix (etranacogene dezaparvovec), the first gene therapy treatment for hemophilia B, with a staggering manufacturer price of $3.5 million, according to GlobalData’s Price Intelligence (POLI), making it the most expensive drug in the world. This is not the first treatment to come with a high price tag.

FDA 105

FDA 105

Speaker: Chris Antypas and Josh Halladay

Access to limited distribution drugs and payer contracts are key to pharmacy expansion. But how do you prepare your operations to take the next step? Meaningful data: Collect and share clinical data regarding outcomes, utilization, and more Reporting: Limited distribution models require efficient tracking and reporting systems Workflows: Align workflows with specific pharma and payer contractual requirements For in-depth, expert insights on pharmacy expansion, watch this webinar from Inovalon.

The Checkup by Singlecare

FEBRUARY 10, 2023

If you’re one of the nearly 50% of Americans with hypertension, your healthcare provider may prescribe a beta blocker like Lopressor ( metoprolol ), Inderal ( propranolol ), or Tenormin ( atenolol ) to lower your blood pressure. Beta blockers are medications that limit the effects of epinephrine, a hormone that constricts blood vessels and increases the rate and force of heart contractions, according to the Mayo Clinic.

Mayo Clinic 98

Mayo Clinic 98

Pharmaceutical Technology

FEBRUARY 10, 2023

AbbVie has reported full-year 2022 net revenues of $58.054bn, representing a 3.3% rise on a reported basis and 5.1% on an operational basis. The company reported an increase of 1.6% on a reported basis in global net revenues to $15.121bn for the fourth quarter (Q4) of 2022. For the full-year, worldwide net revenues from the Immunology portfolio stood at $28.924bn, increasing 14.4% on a reported basis.

98

98

STAT

FEBRUARY 10, 2023

The American Heart Association has released its 2023 Statistical Update and the results are grim: In 2020, the first year of the Covid-19 pandemic, more people died from cardiovascular-related causes than ever before: a staggering 928,741 deaths. While there are many causes of this increase, one is the increased burden that Covid-19 wrought on individuals’ bodies and entire systems.

89

89

The Checkup by Singlecare

FEBRUARY 10, 2023

Overview: What does low heart rate ( bradycardia ) feel like? Low heart rate, or bradycardia , occurs when the heart beats too slowly. Fewer than 60 beats per minute is considered too slow for most people, though a slow heart rate may be normal during sleep or for physically fit people. Healthcare professionals consider bradycardia to be an abnormal heart rhythm problem or arrhythmia.

Mayo Clinic 94

Mayo Clinic 94

STAT

FEBRUARY 10, 2023

The CAR-T cancer therapy called Abecma reduced the risk of multiple myeloma relapse by half compared to standard treatment, according to results of a Phase 3 clinical trial published Friday. The positive study outcome could lead to Abecma being used earlier in the course of treatment for patients with multiple myeloma, a type of blood cancer affecting cells in the bone marrow.

89

89

European Pharmaceutical Review

FEBRUARY 10, 2023

The Cell and Gene Therapy Catapult (CGT Catapult) has announced its involvement in the development of a major new campus for life science businesses in Stevenage, Hertfordshire. This announcement follows news from July 2022 of an intended £900m joint venture investment by two property firms, to develop a new life sciences campus in Stevenage. The new campus extension will deliver one of the largest campuses of its kind in the UK and Europe.

92

92

Speaker: Dr. Ben Locwin - Biopharmaceutical Executive & Healthcare Futurist

What will the future hold for clinical research? A recent draft from the FDA provides valuable insight. In "Optimizing the Dosage of Human Prescription Drugs and Biological Products for the Treatment of Oncologic Diseases," the FDA notes that "targeted therapies demonstrate different dose-response relationships compared to cytotoxic chemotherapy, such that doses below the Maximum Tolerated Dose (MTD) may have similar efficacy to the MTD but with fewer toxicities.

FDA

Drug Store News

FEBRUARY 10, 2023

This synergistic tri-herb formula features Bael Leef, Garden Cress and Psyllium Husk to help ensure daily regularity, while soothing the stomach and intestines.

98

98

Drug Topics

FEBRUARY 10, 2023

Advocates can specialize in order to provide more targeted assistance for patients.

112

112

Fierce Healthcare

FEBRUARY 10, 2023

How the current economic downturn impacts healthcare funding and investor strategy agliadkovskaya Fri, 02/10/2023 - 10:37

113

113

STAT

FEBRUARY 10, 2023

Google and Facebook. Coca-Cola and Pepsi. Those tech and pop conglomerates are considered to be duopolists in their fields. But even they can’t hold a candle to hospitals’ market power. A recent financial filing from a large, tax-exempt hospital system in Orlando provides a glimpse, and serves as a reminder, of just how concentrated America’s hospital markets are.

Hospitals 84

Hospitals 84

Advertisement

Are you still using workarounds to manage your daily operations? To achieve peak performance, it's time to explore other options for specialty and infusion pharmacy software. Streamline pharmacy operations and improve clinical performance with automated processing, real-time data exchange, and electronic decision support. Download this helpful infographic to: Drive efficiency and patient adherence from referral receipt to delivery and ongoing care – all with our Pharmacy Cloud.

Pharmacy Management Software

Drug Topics

FEBRUARY 10, 2023

A phase 2 study of povorcitinib demonstrated sustained and durable efficacy after 1 year of treatment.

98

98

Drug Store News

FEBRUARY 10, 2023

Kiss Colors & Care launched a new styling collection and unveiled international rapper, songwriter and model JT as its latest brand partner.

98

98

Drug Topics

FEBRUARY 10, 2023

The FDA has updated its compounding guidelines for licensed pharmacies, hospitals, and health systems.

FDA 98

FDA Compounding Hospitals 98

STAT

FEBRUARY 10, 2023

CVS Health’s acquisition of Oak Street Health , a Medicare-focused primary care provider, for $10.6 billion is just the latest in a string of primary care clinic buyouts by other retailers and insurance companies. Amazon, Walgreens Boots Alliance, and Cigna have already thrown their chips on the table, investing in or outright purchasing primary care clinic organizations.

Insurance 79

Insurance 79

Fierce Healthcare

FEBRUARY 10, 2023

Albertsons launches app uniting pharmacy, nutrition and telehealth aburky Fri, 02/10/2023 - 16:29

113

113

STAT

FEBRUARY 10, 2023

Hired someone new and exciting? Promoted a rising star? Finally solved that hard-to-fill spot? Share the news with us, and we’ll share it with others.  That’s right. Send us your changes, and we’ll find a home for them. Don’t be shy. Everyone wants to know who is coming and going. And here is our regular feature in which we highlight a different person each week.

77

77

Drug Store News

FEBRUARY 10, 2023

At Hy-Vee's OpportUNITY Inclusive Business Summit, the retailer awarded $50,000 to local minority and women-owned businesses.

98

98

Fierce Pharma

FEBRUARY 10, 2023

Nearing FDA approval anniversary, Phathom gets more bad news on Voquezna impurities fkansteiner Fri, 02/10/2023 - 08:45

FDA 87

FDA 87

Drug Store News

FEBRUARY 10, 2023

The beauty brand’s products are now available at more than 1,300 Ulta Beauty stores across the nation and online.

98

98

Fierce Healthcare

FEBRUARY 10, 2023

Which payer raked in the most cash last year?

128

128

Fierce Pharma

FEBRUARY 10, 2023

ABPI president, a Novo Nordisk exec, steps down after company's code breaches zbecker Fri, 02/10/2023 - 11:32

88

88

Fierce Healthcare

FEBRUARY 10, 2023

Task force reaffirms 2016 ruling on screening for genital herpes fdiamond Fri, 02/10/2023 - 13:59

98

98

Fierce Pharma

FEBRUARY 10, 2023

Roche's Vabysmo shows an edge over Regeneron's Eylea in retina drying kdunleavy Fri, 02/10/2023 - 10:08

89

89

Pharmafile

FEBRUARY 10, 2023

GSK announced that its treatment for recurrent or advanced mismatch repair-deficient (dMMR) endometrial cancer has been granted full approval by the FDA. Jemperli (dostarlimab-gxly) is a programmed death receptor-1 (PD-1)-blocking antibody which binds to the PD-1 receptor and blocks its interaction with the PD-1 ligands PD-L1 and PD-L2. The FDA’s approval was based on data collected from the A1 expansion cohort of the ongoing GARNET trial.

FDA 59

FDA Communication 59

Drug Store News

FEBRUARY 10, 2023

Two months after filing for Chapter 11 bankruptcy protection, Brooklyn, N.Y.-based Medly Pharmacy is selling its pharmacy assets to Walgreens for $19.35 million.

59

59

Fierce Pharma

FEBRUARY 10, 2023

Patient-First, Patient-Focused: Rare Disease Day 2023 jpiatt Fri, 02/10/2023 - 13:35

79

79

Fierce Healthcare

FEBRUARY 10, 2023

Henry Ford, MSU, Pistons dunk $2.

108

108

Fierce Pharma

FEBRUARY 10, 2023

Bristol Myers details landmark Abecma multiple myeloma data that ASH turned down aliu Fri, 02/10/2023 - 10:51

75

75

Pharmafile

FEBRUARY 10, 2023

SynaptixBio, a UK-based biotech firm, has been granted FDA Rare Paediatric Disease (RPD) designation – an accolade which encourages the development of new drugs which are indicated for rare diseases with highly unmet needs. The designation is also the first step to obtaining a Priority Review Voucher (PRV), which can accelerate market access for therapeutics and allow them to be sold or traded by sponsors, including large pharma companies.

FDA 52

FDA 52

BuzzRx

FEBRUARY 10, 2023

The tonsils are two fleshy, oval-shaped pads of tissue located at the back of the throat, one on each side. They are a part of the body’s immune system and stop germs from entering through the mouth and nose. An inflammation of the tonsils is called tonsillitis. It is a common childhood illness in which school-age children between 5 and 15 years make up the majority of cases of tonsillitis, but adults can develop symptoms of tonsillitis too.

Immunization 52

Immunization Hospitals 52